GNE-490
CAS No. 1033739-92-2
GNE-490 ( GNE490 )
Catalog No. M10164 CAS No. 1033739-92-2
GNE-490 is a potent, selective, orally available class I PI3K inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 312 | Get Quote |
|
10MG | 507 | Get Quote |
|
25MG | 802 | Get Quote |
|
50MG | 1107 | Get Quote |
|
100MG | 1503 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGNE-490
-
NoteResearch use only, not for human use.
-
Brief DescriptionGNE-490 is a potent, selective, orally available class I PI3K inhibitor.
-
DescriptionGNE-490 is a potent, selective, orally available class I PI3K inhibitor with IC50 of 3.5/25/5.2/15 nM for PI3Kα/PI3Kβ/PI3Kγ/PI3Kδ; shows >200-fold selectivity over mTOR (IC50=740 nM); has good PK profiles, and are efficacious in xenograft models.
-
SynonymsGNE490
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1033739-92-2
-
Formula Weight386.47
-
Molecular FormulaC18H22N6O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=NC(=NC=C1C2=NC3=C(C(=N2)N4CCOCC4)SC(=C3)C(C)(C)O)N
-
Chemical Name2-(2-Amino-4-methyl-5-pyrimidinyl)-α,α-dimethyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidine-6-methanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sutherlin DP, et al. J Med Chem. 2010 Feb 11;53(3):1086-97.
2. Sampath D, et al. Neoplasia. 2013 Jul;15(7):694-711.
2. Sampath D, et al. Neoplasia. 2013 Jul;15(7):694-711.
molnova catalog
related products
-
AZD8835
AZD8835 (AZD-8835) is a potent, selective inhibitor of PI3Kα and PI3Kδ with IC50 of 6.2 and 5.7 nM.
-
AS-041164
AS-041164 is a selective and orally active PI3Kγ isoform inhibitor(IC50 of 70 nM), and shows less activity against PI3Kα, PI3Kβ, and PI3Kδ (IC50s of 240 nM, 1.45 μM, and 1.70 μM, respectively).
-
SN-32976
SN-32976 is a novel, potent and selective class I PI3K and mTOR inhibitor.